394 related articles for article (PubMed ID: 19162222)
21. Genetic basis of congenital generalized lipodystrophy.
Agarwal AK; Barnes RI; Garg A
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):336-9. PubMed ID: 14557833
[TBL] [Abstract][Full Text] [Related]
22. The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation.
Payne VA; Grimsey N; Tuthill A; Virtue S; Gray SL; Dalla Nora E; Semple RK; O'Rahilly S; Rochford JJ
Diabetes; 2008 Aug; 57(8):2055-60. PubMed ID: 18458148
[TBL] [Abstract][Full Text] [Related]
23. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
Zhou H; Lei X; Yan Y; Lydic T; Li J; Weintraub NL; Su H; Chen W
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31185001
[TBL] [Abstract][Full Text] [Related]
24. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.
Kim CA; Delépine M; Boutet E; El Mourabit H; Le Lay S; Meier M; Nemani M; Bridel E; Leite CC; Bertola DR; Semple RK; O'Rahilly S; Dugail I; Capeau J; Lathrop M; Magré J
J Clin Endocrinol Metab; 2008 Apr; 93(4):1129-34. PubMed ID: 18211975
[TBL] [Abstract][Full Text] [Related]
25. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
[TBL] [Abstract][Full Text] [Related]
27. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus.
Jin J; Cao L; Zhao Z; Shen S; Kiess W; Zhi D; Ye R; Cheng R; Chen L; Yang Y; Luo F
Eur J Endocrinol; 2007 Dec; 157(6):783-7. PubMed ID: 18057387
[TBL] [Abstract][Full Text] [Related]
28. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
[TBL] [Abstract][Full Text] [Related]
29. Oligomers of the lipodystrophy protein seipin may co-ordinate GPAT3 and AGPAT2 enzymes to facilitate adipocyte differentiation.
Sim MFM; Persiani E; Talukder MMU; Mcilroy GD; Roumane A; Edwardson JM; Rochford JJ
Sci Rep; 2020 Feb; 10(1):3259. PubMed ID: 32094408
[TBL] [Abstract][Full Text] [Related]
30. Function of seipin: new insights from Bscl2/seipin knockout mouse models.
Dollet L; Magré J; Cariou B; Prieur X
Biochimie; 2014 Jan; 96():166-72. PubMed ID: 23831461
[TBL] [Abstract][Full Text] [Related]
31. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
32. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology.
Szymanski KM; Binns D; Bartz R; Grishin NV; Li WP; Agarwal AK; Garg A; Anderson RG; Goodman JM
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20890-5. PubMed ID: 18093937
[TBL] [Abstract][Full Text] [Related]
33. Mouse models of lipodystrophy and their significance in understanding fat regulation.
Rochford JJ
Curr Top Dev Biol; 2014; 109():53-96. PubMed ID: 24947236
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
[TBL] [Abstract][Full Text] [Related]
35. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders.
Garg A
J Clin Endocrinol Metab; 2011 Nov; 96(11):3313-25. PubMed ID: 21865368
[TBL] [Abstract][Full Text] [Related]
36. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy.
Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H
Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797
[TBL] [Abstract][Full Text] [Related]
37. Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans.
Bai X; Smith HE; Golden A
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38454882
[TBL] [Abstract][Full Text] [Related]
38. Role of Seipin in Human Diseases and Experimental Animal Models.
Li Y; Yang X; Peng L; Xia Q; Zhang Y; Huang W; Liu T; Jia D
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740965
[TBL] [Abstract][Full Text] [Related]
39. Seipin ablation in mice results in severe generalized lipodystrophy.
Cui X; Wang Y; Tang Y; Liu Y; Zhao L; Deng J; Xu G; Peng X; Ju S; Liu G; Yang H
Hum Mol Genet; 2011 Aug; 20(15):3022-30. PubMed ID: 21551454
[TBL] [Abstract][Full Text] [Related]
40. Seipin: from human disease to molecular mechanism.
Cartwright BR; Goodman JM
J Lipid Res; 2012 Jun; 53(6):1042-55. PubMed ID: 22474068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
